Our studies have demonstrated that AFP has the capability a capacity to contribute to the proliferation of both tumor and normal cells[6] and facilitate the liver cancer cells escaping from immune surveillance by blocking the caspase signaling pathway of tumor cells, and triggering the Fas/FasL interaction between tumor cells and lymphocytes[7]. This evidence concerns the gene AFP and liver cancer.